Structural analysis of lipid complexes of GM2-activator protein

Journal of Molecular Biology

Volumn 331, Issue 4, 2003, Pages 951-964

  Wright, Christine Schubert ^a   Zhao, Qiang ^a,b   Rastinejad, Fraydoon ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

GM2 ganglioside; GM2 activator protein; Lipid binding site; Protein dynamics

Indexed keywords

ACTIVATOR PROTEIN GM2; CERAMIDE; LIPID BINDING PROTEIN; MONOMER; PHOSPHOLIPID; TRYPTOPHAN; UNCLASSIFIED DRUG;

ARTICLE; CRYSTALLOGRAPHY; HYDROPHOBICITY; MEMBRANE BINDING; MOLECULAR MODEL; PH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN STRUCTURE;

EID: 0042667012     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00794-0     Document Type: Article

References (48)

1. Wright C.S., Li S.-C., Rastinejad F. Crystal structure of human GM2-activator protein with a novel β-cup fold. J. Mol. Biol. 304:2000;411-422.
2. Ahn V.E., Faull K.F., Whitelegge J.P., Fluharty A.L., Prive G.G. Crystal structure of saposin B reveals a dimeric shell for lipid binding. Proc. Natl Acad. Sci. USA. 100:2002;38-48.
3. Li Y.-T., Li S.-C. Activator proteins related to the hydrolysis of glycosphingolipids catalyzed by lysosomal glycosidases. Dingle J.T., Dean R.T., Sly W. Lysosmes in Biology and Pathology. 1984;99-117 Elsevier Science Ltd, Amsterdam.
4. Fürst W., Sandhoff K. Activator proteins and topology of lysosomal sphingolipid catabolism. Biochim. Biophys. Acta. 1126:1992;1-16.
5. Wilkening G., Linke T., Sandhoff K. Lysosomal degradation on vesicular surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators. J. Biol. Chem. 273:1998;30271-30278.
6. Kolter T., Sandhoff K. Sphingolipids, their metabolism pathways and the pathobiochemistry of neurodegenerative diseases. Angew. Chem. Int. Ed. 38:1999;1532-1568.
7. Mahuran D.J. The GM2 activator protein, its roles as a co-factor in GM2 hydrolysis and as a general glycolipid transport protein. Biochim. Biophys. Acta. 1393:1998;1-18.
8. Mahuran D.J. Biochemical consequences of mutations causing the GM2 gangliosidoses. Biochim. Biophys. Acta. 1455:1999;105-138.
9. Smiljanic-Georgijev N., Rigat B., Xie B., Wang W., Mahuran D.J. Characterization of the affinity of the GM2 activator protein for glycolipids by Fluorescence dequenching assay. Biochim. Biophys. Acta. 1339:1997;192-202.
10. Yadao F., Hechtman P., Kaplan F. Formation of a ternary complex between GM2 activator protein, GM2 ganglioside and hexosaminidase A. Biochim. Biophys. Acta. 1340:1997;45-52.
11. Conzelmann E., Burg J., Stephan G., Sandhoff K. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2. Eur. J. Biochem. 123:1982;455-464.
12. Rigat B., Reynaud D., Smiljanic-Georgijev N., Mahuran D. The GM2 activator protein, a novel inhibitor of platelet-activating factor. Biochem. Biophys. Res. Commun. 258:1999;256-259.
13. Rigat B., Wang W., Leung A., Mahuran D.J. Two mechanisms for the recapture of extracellular GM2 activator protein: evidence for a major secretory form of the protein. Biochemistry. 36:1997;8325-8331.
14. Nakamura S.-I., Akisue T., Jinnai H., Hitomi T., Sarkar S., Miwa N., et al. Requirement of GM2 ganglioside activator for phopholipase D activation. Proc. Natl Acad. Sci. USA. 95:1998;12249-12253.
15. Wright C.S., Li S.-C. Crystallization and preliminary X-ray characterization of GM2-activator protein. Acta Crystallog. sect. D. 53:1997;211-212.
16. The CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D. 50:1994;760-763.
17. Beamer L.J., Carroll S.F., Eisenberg D. Crystal structure of human BPI and two bound phospholipids at 2.4 Å resolution. Science. 276:1997;1861-1864.
18. Clayton G.M., Peak-Chew S.Y., Evans R.M., Schwabe J.W.R. The Structure of the ultraspiracle ligand-binding domain reveals a nuclear receptor locked in an inactive conformation. Proc. Natl Acad. Sci. USA. 98:2000;1549-1554.
19. Billas I.M.L., Moulinier L., Rochel N., Moras D. Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects. J. Biol. Chem. 276:2001;7465-7474.
20. Thompson J., Ory J., Reese-Wagoner A., Banaszak L. The liver fatty acid binding protein - comparison of cavity properties of intracellular lipid binding proteins. Mol. Cell. Biochem. 192:1999;9-16.
21. 1H NMR study of GM2 ganglioside: evidence that an inter-residue amide-carboxyl hydrogen bond contributes to stabilization of a preferred conformation. Glycoconj. J. 8:1991;484-492.
22. Bernardi A., Arosio D., Sonnino S. Mimicking gangliosides by design: mimics of GM1 headgroup. Neurochem. Res. 27:2002;539-545.
23. Brocca P., Bernardi A., Raimondi L., Sonnino S. Modeling ganglioside head groups by conformational analysis and molecular dynamics. Glycoconj. J. 17:2000;283-299.
24. Schouten A., Agianian B., Westerman J., Kroon J., Wirtz K.W.A., Gros P. Structure of apo-phosphatidylinositol transfer protein α provides insight into membrane association. EMBO J. 21:2002;2117-2121.
25. Yoder M.D., Thomas L.M., Tremblay J.M., Oliver R.L., Yarbrough L.R., Helmkamp G.M. Jr. Structure of a multifunctional protein. Mammalian phosphatidylinositol transfer protein complexed with phosphatidylcholine. J. Biol. Chem. 276:2001;9246-9252.
26. Segelke B.W., Forstner M., Knapp M., Trakhanov S.D., Parkin S., Newhouse Y.M., et al. Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: implications for lipid binding. Protein Sci. 9:2000;886-897.
27. Banaszak L., Winter N., Xu Z., Bernlohr D.A., Cowan S., Jones T.A. Lipid-binding proteins: a family of fatty acid and retinoid transport proteins. Advan. Protein Chem. 45:1994;89-151.
28. Feng J., Wehbi H., Roberts M.F. Role of tryptophan residues in interfacial binding of phosphatidylinositol-specific phospholipase C. J. Biol. Chem. 277:2002;19867-19875.
29. Roderick S.L., Chan W.W., Agate D.S., Olsen L.R., Vetting M.W., Rajashankar K.R., Cohen D.E. Structure of human phosphatidylcholine transfer protein in complex with its ligand. Nature Struct. Biol. 9:2002;507-511.
30. Thompson J.R., Banaszak L.J. Lipid-protein interactions in lipovitellin. Biochemistry. 41:2002;9398-9409.
31. Hama Y., Li Y.-T., Li S.-C. Interaction of GM2 activator protein with glycosphingolipids. J. Biol. Chem. 272:1997;2828-2833.
32. Giehl A., Lemm T., Bartelsen O., Sandhoff K., Blume A. Interaction of the GM2-activator protein with phospholipid-ganglioside bilayer membranes and with monolayers at the air-water interface. Eur. J. Biochem. 261:1999;650-658.
33. Brown R.E., Stephenson F.A., Markello T., Barenholz Y., Thompson T.E. Properties of a specific glycolipid transfer protein from bovine brain. Chem. Phys. Lipids. 38:1985;79-83.
34. Malenbaum S.E., Collier R.J., London E. Membrane topography of the T domain of diphtheria toxin probed with single tryptophan mutants. Biochemistry. 37:1998;17915-17922.
35. Lookene A., Groot N.B., Kastelein J.J., Olivecrona G., Bruin T. Mutation of tryptophan residues in lipoprotein lipase. Effects on stability, immunoreactivity, and catalytic properties. J. Biol. Chem. 272:1997;766-772.
36. Gelb M.H., Cho W., Wilton D.C. Interfacial binding of secreted phospholipases A2: more than electrostatics and a major role for tryptophan. Curr. Opin. Struct. Biol. 9:1999;425-427.
37. Ravasi D., Masserini M., Vecchio G., Li Y.T., Li S.-C. Study of interaction of GM2 activator protein with GM2 using circular dichroism and fluorescence spectroscopy. Neurochem. Res. 27:2002;785-792.
38. Yuziuk J.A., Bertoni C., Beccari T., Orlacchio A., Wu Y.-Y., Li S.-C., Li Y.-T. Specificity of mouse GM2 activator protein and β-N-acetyl-hexosaminidase A and B. J. Biol. Chem. 273:1998;66-72.
39. Wu Y.Y., Lockyer J.M., Sugiyama E., Pavlova N.V., Li Y.-T., Li S.-C. Expression and specificity of human GM2 activator protein. J. Biol. Chem. 269:1994;16276-16283.
40. Bertoni C., Li Y.-T., Li S.-C. Catabolism of asialo-GM2 in man and mouse. J. Biol. Chem. 274:1999;28612-28618.
41. 138 is required for the recognition of the GM2 ganglioside complex by β-hexosaminidase A. Biochemistry. 37:1998;814-821.
42. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
43. Brünger A.T., Adams P.D., Clore G.M., DeLano W.L., Gross P., Grosse-Kunstleve R.W., et al. Crystallographic and NMR system - a new software suite for macromolecular structure determination. Acta Crystallog. sect. D. 54:1998;905-921.
44. Perrakis A., Morris R., Lamzin V.S. Automated protein model building combined with iterative structure refinement. Nature Struct. Biol. 6:1999;458-463.
45. Jones T.A., Kjeldgaard M.O. Version 5.9, The Manual. 1993;Uppsala University, Uppsala, Sweden.
46. Kleywegt G.T., Jones T.A. Databases in protein crystallography. Acta Crystallog. sect. D. 54:1998;119-1131.
47. Liang J., Edelsbrunner H., Woodward C. Anatomy of protein pockets and cavities: measurement of binding site geometry and implications for ligand design. Protein Sci. 7:1998;1884-1897.
48. Vaskorsky V.E., Svetashev V.I. Phospholipid spray reagents. J. Chromatog. 65:1972;451-453.